# Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

> **NCT00898014** · — · COMPLETED · sponsor: **Institut Curie** · enrollment: 216 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **GENETIC:** fluorescence in situ hybridization
- **OTHER:** immunologic technique
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00898014
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-04
- **Final completion:** —
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2011-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898014, "Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00898014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*